Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medibank Private ( (AU:MPL) ) just unveiled an announcement.
Medibank has been ordered to hand over three Deloitte reports on its 2022 cybercrime incident to applicants in an ongoing consumer class action, after the Full Federal Court refused its bid for leave to appeal an earlier Federal Court ruling. The courts found the reports were not protected by legal professional privilege, a decision that increases legal transparency around Medibank’s cyber response and could influence the course of litigation and disclosure expectations for cyber incidents in Australia.
The ruling compels Medibank to produce the reports under an agreed confidentiality regime, balancing plaintiffs’ access to information with some protection of sensitive material. The outcome underscores growing judicial scrutiny of attempts to shield external cyber-review documents and may have implications for how Australian companies structure post-breach investigations and manage legal risk in future cyber events.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.10 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a major Australian private health insurer that provides health insurance products and related health services to consumers across the country. The company operates under the Medibank brand and focuses on retail health coverage and ancillary services within Australia’s private healthcare system.
Average Trading Volume: 6,501,321
Technical Sentiment Signal: Buy
Current Market Cap: A$11.92B
See more insights into MPL stock on TipRanks’ Stock Analysis page.

